Therapeutics News

Topline results from the phase 2b RELIEF trial demonstrate that licaminlimab has the potential to reshape the treatment paradigm of dry eye disease, offering a more precise strategy than current methods.

NASHVILLE, Tenn. — Patients with dry eye disease prescribed Miebo eye drops had a higher 60-day refill rate compared with those using cyclosporine ophthalmic emulsion, according to a poster at Optometry’s Meeting.

NASHVILLE, Tenn. — A clinician shared his experience using Vevye in a post-cataract surgery patient with autoimmune disease in this Healio video at Optometry’s Meeting.

NASHVILLE, Tenn. — Alcon’s U.S. pharmaceutical division shared its focus on glaucoma and dry eye with attendees at Optometry’s Meeting.

NASHVILLE, Tenn. — Short-term noninvasive tear breakup time increased with use of Lumify eye drops in cohort of patients with and without dry eye disease, according to a poster presented at Optometry’s Meeting.

NASHVILLE, Tenn. — A preservative-free brimonidine tartrate ophthalmic solution was statistically noninferior to Bausch + Lomb’s Lumify, offering an alternative option for ocular redness relief, according to a poster at Optometry’s Meeting.

Vevye, a nonpreserved cyclosporine 0.1% ophthalmic solution, demonstrated sustained safety and efficacy among patients with dry eye disease, according to 52-week ESSENCE-2 open-label extension study results published in Cornea.

Opthea has completed enrollment of its phase 3 COAST and ShORe trials, which will investigate the safety and efficacy of sozinibercept in combination with anti-VEGF-A therapy for wet age-related macular degeneration.

Lubricating eye drops with a single-polymer or dual-polymer formulation and saline were all effective in reducing epithelial surface irregularity along the horizontal meridian in a study published in Optometry and Vision Science.

EyeCRO announced that its Microemulsion Drug Ocular Penetration System, or MiDROPS, demonstrated safety and efficacy in its first clinical application as a topical eye drop vehicle for dry eye disease.